| Ident. | Authors (with country if any) | Title |
|---|
| 003409 |
Mervin C. Yoder [États-Unis] ; Vanta J. Jokubaitis [Australie] ; Lidia Sinka [France] ; Rebecca Driessen [Australie] ; Genevieve Whitty [Australie] ; David N. Haylock [Australie] ; Ivan Bertoncello [Australie] ; Lan Smith [Australie] ; Bruno Peault [États-Unis] ; Manuela Tavian [France] ; Paul J. Simmons [Australie, États-Unis] | Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Commentary |
| 003737 |
Christopher G. Bell [Royaume-Uni, Australie] ; David Meyre [France] ; Enrico Petretto [Royaume-Uni] ; Claire Levy-Marchal [France] ; Serge Hercberg [France] ; Marie Aline Charles [France] ; Cliona Boyle [Royaume-Uni] ; Jacques Weill [France] ; Maïte Tauber [France] ; Charles A. Mein [Royaume-Uni] ; Timothy J. Aitman [Royaume-Uni] ; Philippe Froguel [Royaume-Uni, France] ; Andrew J. Walley [Royaume-Uni] | No contribution of angiotensin-converting enzyme (ACE) gene variants to severe obesity : a model for comprehensive case/control and quantitative cladistic analysis of ACE in human diseases |
| 004867 |
Jean-Michel Mallion [France] ; Bernard Chamontin [France] ; Roland Asmar [France] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Eoin O'Brien [Irlande (pays)] ; Daniel Duprez [Belgique, États-Unis] ; Michael F. O'Rourke [Australie] ; Karl-Heinz Rahn [Allemagne] ; Ramon Romero [Espagne] ; Edouard Battegay [Suisse] ; Gerhart Hitzenberger [Autriche] ; Michel E. Safar [France] | Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study |
| 004A11 |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
| 004D28 |
John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
| 005271 |
R. G. Langham [Australie] ; D. J. Kelly [Australie] ; A. J. Cox [Australie] ; N. M. Thomson [Australie] ; H. Holthöfer [Finlande] ; P. Zaoui [France] ; N. Pinel [France] ; D. J. Cordonnier [France] ; R. E. Gilbert [Australie] | Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition |
| 005300 |
Victor J. Dzau [États-Unis] ; Kenneth Bernstein [États-Unis] ; David Celermajer [Australie] ; Jerome Cohen [États-Unis] ; Björn Dahlöf [Suède] ; John Deanfield [Royaume-Uni] ; Javier Diez [Espagne] ; Helmut Drexler [Allemagne] ; Roberto Ferrari [Italie] ; Wiek Van Gilst [Pays-Bas] ; Lennart Hansson [Suède] ; Burkhard Hornig [Allemagne] ; Ahsan Husain [Australie] ; Colin Johnston [Australie] ; Harold Lazar [États-Unis] ; Eva Lonn [Canada] ; Thomas Lüscher [Suisse] ; John Mancini [Canada] ; Albert Mimran [France] ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka ; Heribert Schunkert ; Karl Swedber ; Thomas Unger ; Douglas Vaughan ; Michael Weber | Pathophysiologic and therapeutic importance of tissue ACE: A consensus report |
| 006016 |
JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France] | Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure |
| 006609 |
J. Menard [France] ; D. J. Campbell [Australie] ; M. Azizi [France] ; M.-F. Gonzales [France] | Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats |
| 006D10 |
J. L. Rodicio [Espagne] ; L. M. Ruilope | Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension |
